Citation Tools
PDFRegular and young investigator award abstracts
Immune-stimulants and immune modulators
564 Potency-reduced and extended half-life IL12 heterodimeric Fc-fusions exhibit strong anti-tumor activity with potentially improved therapeutic index compared to native IL12 agents
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 564 Potency-reduced and extended half-life IL12 heterodimeric Fc-fusions exhibit strong anti-tumor activity with potentially improved therapeutic index compared to native IL12 agents